Painreform Enterprise Value Over E B I T D A from 2010 to 2025
| PRFX Stock | USD 2.57 0.05 1.91% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.52) | Current Value (0.55) | Quarterly Volatility 736.23112445 |
Check Painreform financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Painreform's main balance sheet or income statement drivers, such as Interest Expense of 362.5 K, Tax Provision of 6.8 K or Depreciation And Amortization of 18.1 K, as well as many indicators such as Price To Sales Ratio of 982, Dividend Yield of 0.0 or PTB Ratio of 1.76. Painreform financial statements analysis is a perfect complement when working with Painreform Valuation or Volatility modules.
Painreform | Enterprise Value Over E B I T D A |
Latest Painreform's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Painreform over the last few years. It is Painreform's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Painreform Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (363.89) | |
| Geometric Mean | 46.20 | |
| Coefficient Of Variation | (202.32) | |
| Mean Deviation | 505.43 | |
| Median | (79.11) | |
| Standard Deviation | 736.23 | |
| Sample Variance | 542,036 | |
| Range | 2.2K | |
| R-Value | (0.07) | |
| Mean Square Error | 577,517 | |
| R-Squared | 0.01 | |
| Significance | 0.78 | |
| Slope | (11.54) | |
| Total Sum of Squares | 8.1M |
Painreform Enterprise Value Over E B I T D A History
About Painreform Financial Statements
Painreform investors use historical fundamental indicators, such as Painreform's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Painreform. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.52) | (0.55) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.